Swaza

It was an honor for Swaza to be on the CTA Center Stage at?#CES2023?to open the Global Innovation Startup Showcase. When we think about global challenges that need focused and scalable tech solutions, we can't help but think about how respiratory illness has shaped our world for the last three years--and will continue to challenge us as new threats emerge, as global cities experience environmental stress, and as populations age. The pandemic highlighted a shocking truth: we do not have simple, effective solutions for respiratory distress. Swaza is working to change this with a revolutionary nanofluid breathing aid designed to improve oxygen delivery even in damaged lungs or in extreme conditions---all without the need for complicated equipment or invasive, expensive treatments. This technology will be an important asset for the world's medical resiliency and will save lives.??

Swaza had the distinct pleasure to present at the 2024 BARDA Innovation Summit where we presented our cutting edge research and development efforts. We also thank Principal Deputy Assistant Secretary and Chief Operating Officer at HHS Administration for Strategic Preparadness and Response, Nikki Bratcher-Bowman for her support of our medical countermeasure efforts.

For those of you interested in learning more about what we are building at Swaza, join us at Stanford University as we present at the Stanford Wearable Electronics Initiative (eWEAR) Health Prize Showcase. Join us and show your support for oxygen nano therapeutics.

Niki V. Santo speaking to a packed room at Marathon Fund's Applied AI in Health Event about emerging innovations in health, AI, and early stage biotech R&D.

We are thrilled to be a part of such a vibrant community of startups featured at our New York office! ?? (companies are listed alphabetically) As a Blue Knight company with Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), Swaza Inc. is at the forefront of healthcare innovation. Our presence marks a significant milestone in our journey and reflects our commitment to bringing innovative solutions closer to our partners. We look forward to leveraging the opportunities that New York has to offer and are excited about the impactful work we will accomplish together. Stay tuned for updates on our upcoming initiatives and events. New York City Economic Development Corporation

We are thrilled to be a part of such a vibrant community of startups featured at our New York office! ?? (companies are listed alphabetically) As a Blue Knight company with Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), Swaza Inc. is at the forefront of healthcare innovation. Our presence marks a significant milestone in our journey and reflects our commitment to bringing innovative solutions closer to our partners. We look forward to leveraging the opportunities that New York has to offer and are excited about the impactful work we will accomplish together. Stay tuned for updates on our upcoming initiatives and events. New York City Economic Development Corporation

Swaza was recognized with the People’s Choice Award at the Poster Showcase Award session at the 2024 Blue Knight Symposium. Further, we had the privilege to present our work to Dawn O'Connell, the Assistant Secretary for Preparedness and Response with the U.S. Department of Health and Human Services (HHS). A big thank you to the event organizers, Rachel Rath, and team for organizing a great event. Also a shout out to Melinda Richter and Gary Disbrow (Director of BARDA) for forming and continually supporting the BARDA x JLABS partnership.

CEO Niki V. Santo kicks off our showcase at the 2024 Blue Knight Symposium where she is highlighting the innovative research and development happening at Swaza. Blue Knight is a joint initiative between Johnson & Johnson Innovation – JLABS ('JLABS') and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services.

Exciting news! Swaza made it to the shortlist for the Wolfson Entrepreneurship Competition 2024! Hosted by Wolfson College, University of Cambridge, UK, this global competition celebrates groundbreaking startups. Our team, led by CEO Niki V. Santo, Queens' College, Cambridge, and Artem A. Trotsyuk will?pitch?during the?competition final on March 17, 2024.?We're incredibly grateful for this opportunity and excited to showcase?Swaza's solutions to improve breathing and oxygenation. Thanks to Ronjon Nag and R42 Group for support of University of Cambridge founders. At Swaza, we're pioneering revolutionary oxygen nanotherapeutics, introducing the world's first non-invasive nanofluid breathing aid for respiratory distress. Our innovations are powered by cutting-edge nanotechnology, and we're dedicated to making a positive impact on global health. Stay tuned for more updates as we embark on this thrilling journey! #WolfsonEntrepreneurshipCompetition2024 #Innovation #Nanotechnology #GlobalHealth #StartupJourney

We are excited to announce that Swaza Inc. has entered into a transformative partnership with the Biomedical Advanced Research and Development Authority (BARDA) Division of Research, Innovation, and Ventures (DRIVe) program. Together, we are embarking on an unprecedented journey to revolutionize the treatment of acute respiratory distress syndrome (ARDS). This partnership marks a significant milestone in Swaza's ongoing mission to address the critical need for enhanced ARDS treatments. With the support of BARDA's DRIVe program, Swaza Inc. is dedicated to reshaping the standard of care for individuals grappling with respiratory challenges. Read more:?https://lnkd.in/gujuQupK --- Swaza builds revolutionary oxygen therapeutics, including its novel, non-invasive nanofluid breathing aid for respiratory distress. Our innovative solution offers a portable, affordable, and easy-to-use option for addressing hypoxemia on a global scale. With the support of BARDA's DRIVe program, we aim to transform the standard of care for ARDS patients, preventing or minimizing the need for invasive treatments in the ICU. Learn more at www.swaza.life #SwazaInc #HealthcareInnovation #ARDS #Partnership #BARDA #DRIVeProgram #MedicalBreakthroughs